GoodGut will participate at the 14th Congress of the European Crohn’s and Colitis Organisation (ECCO Congress), the major inflamatory bowel disease (IBD) meeting in the world attracting over 6,500 participants, will be held in Copenhagen from 6 to 9 March 2019. The ECCO Congress theme for this year is suitably titled Research drives clinical care where personalised approaches for individual patient treatments will take center stage.
A total of 1,228 abstracts have been submitted to this year’s Congress. A panel of expert reviewers have evaluated and selected the strongest and most scientifically relevant abstracts for presentation. One of them is the RAID-Monitor of GoodGut.
Joan Amoedo, researcher at GoodGut, will present the poster RAID-Monitor: a new non-invasive method to determine endoscopic activity in IBD in the section Clinical, diagnosis and outcome. RAID-Monitor is an accurate bacterial-based biomarker that correlates well with endoscopic activity in both CD and UC patients. Sensitivity and specificity obtained with our method are the highest among the techniques compared. Therefore, RAID-Monitor is a good candidate to become the non-invasive method of choice to monitor the endoscopic activity in both diseases.
Date: 6-9 March, 2019
Place: Bella Center (Copenhagen)